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Improving the Transparency of the Pharmaceutical Supply 
Chain Through the Adoption of Quick Response (QR) 
Code, Internet of Things (IoT), and Blockchain 
Technology: One Result: Ending the Opioid Crisis 




 Over the past two years, Americans in nearly every state have suffered adverse effects from 
counterfeit medications, many of whom have died. The main culprit is Fentanyl-tainted counterfeit opiates 
which often lead to fatal overdoses. The increasing epidemic of counterfeit prescription medications 
extends beyond social classes, gender, race, and age. For instance, pop star Prince recently overdosed on 
counterfeit Hydrocodone containing synthetic Fentanyl. Shockingly, one in ten medications sold in 
developing countries are counterfeit; either containing incorrect doses of active ingredients or containing 
toxic contaminants retained from the production process. The popularity of counterfeit medications stems 
from cheaper costs, but also because of the ease with which these counterfeit products can be purchased. 
While the blockchain has gained its fame from Bitcoin, its potential implications are far reaching. In this 
paper, I propose the use of QR code and the IoT (Internet of Things) sensor devices leveraging the 
blockchain for increased transparency of the pharmaceutical supply chain and manufacturing process. The 
data collected from the devices would then be transferred to the blockchain, enabling consumers to use an 
app to verify the provenance of their medication. 
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Justin D. Evans* 
I. INTRODUCTION: THE PROBLEM 
Counterfeit medications have become one of the most complex and challenging 
problems that modern societies face across the globe. Many entities are tasked with 
protecting pharmaceutical consumers, including both national governments and 
pharmaceutical companies. In this Article, counterfeit drugs are defined as being 
substandard, spurious, falsely labeled, or falsified medicines, making it difficult to 
identify whether the medication is a genuine product.1 Though there have been 
developments in technology already applied to the industry, which one would believe 
should mitigate the spread of counterfeits, the dangers that counterfeit medications 
present to global public health has increased. Between 2005 and 2010 the theft of 
pharmaceuticals increased by 66%, and the incidence of counterfeit medication 
use/production increased by 122% during this same period of time.2 
The prevalence of counterfeit drugs arises from the failure to secure the 
integrity and safety of pharmaceutical companies’ global supply chains.3 These 
global supply chains are often disrupted by large transnational crime organizations.4 
There are two general forms of supply chains: 1) a legitimate supply chain defined 
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1 Counterfeit Medicine, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/drugs/resourcesforyou/ 
consumers/buyingusingmedicinesafely/counterfeitmedicine (last updated Aug. 12, 2016). 
2 Tim K. Mackey et al., Counterfeit Drug Penetration into Global Legitimate Medicine Supply 
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as any supply chain that is regulated by a regulatory body with the expectation that 
the product is authentic and is coming from the manufacturer; and 2) an illicit supply 
chain which is any supply chain that originates from any establishment without 
regulatory supervision, such as bodegas or the internet.5 
Between 2009 and 2011, there were 1,799 different incidents in which 
counterfeit drugs were found to penetrate legitimate supply chains.6 These incidents 
were reported by internal pharmaceutical employees, open source reports, liaisons, 
and joint investigative agencies.7 A recent study revealed that 58% of all counterfeit 
medications were anti-microbial anti-infectives, cardiovascular, central nervous 
system, or alimentary medications. These were the most reported counterfeited 
classes of medications due to their demand.8 Interestingly, incidents in China, Peru, 
Uzbekistan, Russia, and Ukraine make up 65.7% of all those reported.9 This study 
revealed that 127 of 196 countries globally had not reported any incidents of 
counterfeit medication use, presumably due to the lack of effective regulation.10 
Counterfeit drugs are frequently manufactured under unsafe conditions, which 
increases the chances of contaminants being incorporated in the drug and often do 
not contain the appropriate amount of the active ingredient.11 Counterfeiters have 
been found to include toxins like rat poison, road tar, concrete, chalk, boric acid, and 
solvents such as DMSO in their products which can result in adverse reactions or 
death.12 In fact, counterfeit medications for malaria and tuberculosis are said to 
account for over 700,000 deaths annually in developing countries.13 
                                                          
5 THE KAISER FAMILY FOUND., Follow the Pill: Understanding the U.S. Commercial 
Pharmaceutical Supply Chain (Mar. 2005), https://kaiserfamilyfoundation.files.wordpress.com/2013/01/ 
follow-the-pill-understanding-the-u-s-commercial-pharmaceutical-supply-chain-report.pdf. 
6 Mackey et al., supra note 2, at 61. 
7 Mackey et al., supra note 2. 
8 Id. at 62. 
9 INT’L MED. PRODS. ANTI-COUNTERFEITING TASKFORCE, Counterfeit Medicines: An Update on 
Estimates, WORLD HEALTH ORG. (Nov. 15, 2006), https://www.who.int/medicines/services/counterfeit/ 
impact/TheNewEstimatesCounterfeit.pdf. 
10 Id. 
11 Libby Baney & Carmen A. Catizone, Battling the Epidemic of Illegal Online Drug Sellers and 




13 Fake Drugs Kill Over 700,000 People Every Year—New Report, INT’L POLICY NETWORK, 
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Effective tracking and tracing of a medication during its entire supply chain 
cycle could be an effective tool to solve these problems and has already been widely 
adopted by the food industry. The booming Internet of Things (IoT) technologies,14 
quick response (QR) codes,15 and the blockchain technology for supply chains can 
be used to ensure safety.16 QR codes, in combination with IoT, make it possible to 
detect potential safety threats making it possible for a rapid response to deal with 
such threats. They also create confidence with consumers. 
This Article is organized as follows: Section 1 presents the vulnerabilities that 
exist in the pharmaceutical supply chain, Section 2 discusses the populations that are 
vulnerable to counterfeit medication, and Section 3 discusses the mechanisms by 
which counterfeiters target vulnerable populations using platforms like Pinterest. 
Then, Section 4 highlights the mechanisms that pharmaceutical companies have 
started to implement and their shortcomings, Section 5 presents potential solutions 
to the problem by implementing the use of QR codes/IoT and blockchain technology, 
and Section 6 discusses the benefits the system has for pharmaceutical companies. 
Section 7 concludes by explaining how the system could help ease the opioid the 
crisis by highlighting counterfeit controlled substances. 
II. VULNERABILITIES: THE BROKEN SUPPLY CHAIN 
 
                                                          
14 Steve Ranger, What Is the IoT? Everything You Need to Know About the Internet of Things Right 
Now, ZDNET (Aug. 21, 2018), https://www.zdnet.com/article/what-is-the-internet-of-things-everything-
you-need-to-know-about-the-iot-right-now/ (“The Internet of Things, or IoT, refers to the billions of 
physical devices around the world that are now connected to the internet, collecting and sharing data.”). 
15 Margaret Rouse, QR Code (Quick Response Code), WHATIS.COM, https://whatis.techtarget.com/ 
definition/QR-code-quick-response-code (last updated Jan. 2013) (“A QR code (quick response code) is 
a type of 2D bar code that is used to provide easy access to information through a smartphone.”). 
16 Justin Evans, Comment, Curb Your Enthusiasm: The Real Implications of Blockchain in the 
Legal Industry, 11 J. BUS. ENTREPRENEURSHIP & L. 273, 275 (2018) (explaining that a blockchain is a 
continuously growing, virtual distributed ledger comprised of digitally recorded and encrypted, or 
“cryptographically hashed,” data in the form of blocks, with each block cryptographically linked to the 





J o u r n a l  o f  T e c h n o l o g y  L a w  &  P o l i c y  
Volume XIX – 2018-2019 ● ISSN 2164-800X (online) 










The pharmaceutical industry’s supply chain can be considered broken in many 
ways. Many of the American pharmaceutical companies have developed and 
implemented strong infrastructures protecting domestic supply chains but experience 
a break down internationally. This break down can be due to the level of 
sophistication of the vendors and/or suppliers abroad who may not subscribe to the 
use of technology such as updated computers and the IoT. 
Though the United States has one of the safest and most controlled 
pharmaceutical supply chains, there have been recent situations that would cause 
doubt amongst consumers. Counterfeit drugs are often manufactured overseas in 
countries like China, India, Russia, Nigeria, Egypt, and Turkey because of their lack 
of laws regulating the export of these medications.17 The United States accounts for 
less than 1% of the counterfeit drug supply chain. However, it accounts for over 40% 
of the world’s prescription drug sales.18 As many drug companies are based and have 
manufacturing plants in the United States, 80% of the active ingredients used in the 
medications sold in the United States originate from countries that have a high 
counterfeit issue.19 These drugs are then distributed to doctor’s offices at a steep 
discount.20 In 2009, Amed Villa robbed a GlaxoSmithKline Virginia warehouse 
making off with $13 million in pharmaceuticals. The Eli Lilly burglary included 
medications for treating psychiatric disorders, cancer, and heart disease. The robbery 
itself is not the most shocking part, but rather the fact that these stolen medications 
made their way into 22 pharmacies in Texas. 
Additionally, in a separate incident during 2010, the Food and Drug 
Administration (FDA) was able to track a nonactive form of the cancer drug Avastin 
to Montana Health Care Solutions, which is owned by a Canadian company who 
imported the counterfeit medication from Turkey. With a secure supply chain 
pipeline already in place, how is it that stolen medications were able to make it to 
the marketplace? 
In 2015, a federal court in Ohio found that distributors of counterfeit 
medications would fake records to create the illusion that the medication looks 
legitimate to pharmacies. Some of the health care providers looking to make a profit 
often overlook their patient’s safety by selling them counterfeit medications. This is 
evidenced by reports of doctors knowingly purchasing medication from unlicensed 
                                                          
17 INT’L MED. PRODS. ANTI-COUNTERFEITING TASKFORCE, supra note 9, at 2–3. 
18 INT’L MED. PRODS. ANTI-COUNTERFEITING TASKFORCE, supra note 9. 
19 Memorandum from the Comm. on Energy and Commerce to the Subcomm. on Oversight and 
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pharmacies, which often have been found to be counterfeit. McLeod Cancer ordered 
its oncologic medications from a Canadian business up until 2007, when nurses 
raised concerns about the medication. A year later, McLeod Cancer was back to 
ordering the counterfeit medication and billing Medicare for it. Investigators have 
found that at least 79 United States medical practices have purchased counterfeit 
medications from foreign or unlicensed pharmacies.21 
In 2013, President Barack Obama signed a law securing the drug distribution 
system to help combat the issue of counterfeit medications. The new law required 
that by 2017, prescription drug packaging include a serial number to allow for 
tracking of the medication from the manufacturer to the pharmacy or doctor’s office. 
While this is a step in the right direction, it still leaves open the possibility that 
counterfeiters are able to copy the serial numbers or refill the prescription container 
with counterfeit medication. 
III. VULNERABLE POPULATIONS: THE ELDERLY AND ECONOMICALLY 
CHALLENGED 
Counterfeiters often target vulnerable populations like those on fixed income, 
such as the elderly, and those in lower socioeconomic classes because they are unable 
to afford the full price of medications and therefore must turn to alternatives. 
Counterfeiters target individuals that are over the age of 50 because they account for 
71% of all outpatient prescriptions in America. The use of prescription medications 
by elders has risen by 39% over the last decade.22 In fact, 40% of the elderly (65 and 
above) use 5 or more different medications weekly.23 Patients are often lured into 
purchasing medication from unlicensed pharmacy websites because of their drug 
discounts, easy access, and relaxed or non-existent prescription requirements. 
With the expansion of internet commerce, many consumers have started to use 
the internet to complete tasks that range from grocery shopping to car shopping. With 
this has come a false sense of trust in suppliers, including online pharmacies. Many 
of these pharmacies are unlicensed, supplying counterfeit medications that originate 
                                                          
21 Armen Keteyian, U.S. Doctors Buying Unapproved Drugs, CBS NEWS (Dec. 12, 2012, 
12:25 PM), https://www.cbsnews.com/news/us-doctors-buying-unapproved-drugs. 
22 COMMUNITY CATALYST, Protecting Seniors by Ensuring Safe Drug Manufacturing 1 (2011), 
https://www.communitycatalyst.org/doc-store/publications/Protecting_Seniors_Ensuring_Safe_Drug 
Manufacturing.pdf. 
23 Jerry H. Gurwitz, Polypharmacy: A New Paradigm for Quality Drug Therapy in the Elderly?, 
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in China and India.24 In a recent survey that asked 6,000 people if they had purchased 
prescription medications online, 23% confirmed that they had.25 Of the individuals 
that have purchased medications online, 20% have admitted to purchasing from sites 
that were not associated with their insurance or health professional.26 Because of the 
rising cost of prescription medication, 44% of those who have purchased medications 
online admit that they are not associated with a local pharmacy or health insurance 
plan and rely on other consumer’s comments and ratings when deciding to purchase 
online.27 
When the National Association of Boards of Pharmacy (NABP) investigated 
more than 11,000 websites that sell medications, it found that 96% of these sites were 
out of compliance with regulations established by the FDA.28 The NABP found that 
88% of these sites do not require their customers to have a valid prescription when 
allowing the purchase of a specific medication.29 The investigation also revealed that 
50% of these sites offer foreign or non-FDA approved medications.30 Unfortunately, 
the NABP determined that 62% of these sites sold medication that was counterfeit 
or substandard. While it is illegal to import foreign medications, the FDA has chosen 
not to enforce their authority when an individual American citizen imports a small 
quantity of medication.31 The cost of medicine has continued to increase and as a 
result, the Centers for Disease Control and Prevention has reported that over five 
million Americans import medications for personal use.32 It has been estimated that 
in 2014, over 35 million patients were unable to afford their prescription 
                                                          
24 U.S. FOOD AND DRUG ADMIN., Buying Medicines Online? Be Wary, FDA Says 1, 1 (2012), 
https://web.archive.org/web/20170209120644/www.fda.gov/downloads/consumers/consumerupdates/uc




28 NAT’L ASS’N OF BDS. OF PHARMACY, Internet Drug Outlet Identification Program Progress 
Report for State and Federal Regulators 3 (2015), https://nabp.pharmacy/wp-content/uploads/2016/08/ 
NABPIDOIReportJuly2015.pdf. 
29 Id. at 5. 
30 Id. 
31 GABRIEL LEVITT, ONLINE PHARMACIES, Personal Drug Importation and Public Health: Ill-
Considered Enforcement Prevents Access to Safe and Affordable Medication 49 (2015), http://www 
.pharmacychecker.com/online-pharmacies-personal-drug-importation-public-health.pdf. 
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medications.33 As a result of not being able to afford their medication, over 50% of 
these patients reported that their conditions worsened.34 
Studies tracking the trends of counterfeiters have found that these individuals 
have shifted from Botox and Viagra to more lifesaving drugs like those for cancer, 
HIV/AIDS, and high cholesterol.35 This shift by the counterfeiters means they now 
potentially affect a greater majority of citizens.36 The harm that these citizens face is 
that their medications do not contain the appropriate drug and therefore, the patient 
does not receive the appropriate treatment.37 This occurs when a prescription 
container is restocked with the wrong drug, fake medication, or a drug is sold that 
has become inactive due to expiration or subpar storage.38 Fake or ineffective 
medications not only fail to cure a patient but may also contribute to disease 
progression. This is particularly evident in the case of cancer.39 
In addition, patients that purchase medication that has expired or has been 
watered down will be receiving the wrong concentration or dose with the counterfeit 
medication.40 This was the case when a physician was sold a research version of 
Botox that was a stronger dose only intended for research purposes.41 The use of this 
medication by the physicians resulted in their patients suffering from respiratory 
paralysis nearly leading to death.42 
                                                          
33 SARA R. COLLINS ET AL., The Commonwealth Fund, the Rise in Health Care Coverage and 
Affordability Since Health Reform Took Effect 4 (2015), http://www.commonwealthfund.org/~/media/ 
files/publications/issue-brief/2015/jan/1800_collins_biennial_survey_brief.pdf (accessed Sept. 30, 
2016). 
34 USA TODAY, KAISER FAMILY FOUND. & HARVARD SCH. OF PUB. HEALTH, Health Care Costs 
Survey (2005), https://kaiserfamilyfoundation.files.wordpress.com/2013/01/7371.pdf. 






40 Daniel S. Chertow et al., Botulism in 4 Adults Following Cosmetic Injections With an Unlicensed, 
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IV. WHY COUNTERFEITING MEDICATIONS IS THE PERFECT CRIME 
When a drug proves to be ineffective, physicians and nurses alike do not 
normally suspect that the etiology could be a counterfeit medication that was 
prescribed to the patient, but rather a poor clinical outcome that is due to human 
variation.43 Often the patient is also not aware that he/she is taking a counterfeit 
medication until it is too late.44 Physicians traditionally do not inquire into where 
their patients purchase the medication that they have prescribed them, and patients 
are often embarrassed to disclose that the medication was purchased online from an 
unlicensed site.45 When a conflict arises, it is often difficult to reference the 
medication package as it is typically discarded after use. The pills themselves often 
present an issue for retrospective referencing, as they are generally metabolized by 
the patient’s body. “Consequently, no one suspects, no one tells, and any evidence is 
discarded or digested.”46 This collectively results in difficulty in properly 
investigating forensically where, how, and what happened when the patient took the 
counterfeit medication.47 
V. HOW COUNTERFEITERS TARGET VULNERABLE POPULATIONS 
A 2018 report published by the NABP revealed that counterfeiters employ 
social media sites to redirect vulnerable populations to rogue pharmacy sites.48 
NABP conducted a four-week study in which it performed key word searches on 
multiple social media platforms and discovered that multiple social media pages had 
advertisements leading to rogue pharmacy sites. These rogue sites were selling 
commonly counterfeited prescription medications.49 For example, NABP found 66 
sites on Pinterest that were promoting medication, 38% of which were selling 
                                                          
43 Father Was Told Dying Daughter Was Fine After Illegal Vaccination, RADIO FREE ASIA 
(June 29, 2005), https://www.rfa.org/english/china/china_vaccinations-20050629.html. 
44 Id. 
45 Id. 




48 Social Media Sites: The New Wild West for Illegal Online Pharmacies, NAT’L ASS’N OF BDS. OF 







I M P R O V I N G  T H E  T R A N S P A R E N C Y  
Volume XIX – 2018-2019 ● ISSN 2164-800X (online) 










medication illegally.50 The agency has searched for commonly counterfeited lifestyle 
medications on Instagram, Facebook, Twitter, Reddit, and eBay, and it has also 
found that 95% of rogue medication sales websites sell prescription drugs illegally.51 
Fortunately, Snapchat and Twitter require individuals that are advertising 
pharmacies and pharmaceutical products to first be verified by the agency.52 
VI. POTENTIAL SOLUTIONS 
A. The Current System 
Today, there are a number of track and trace applications that pharmaceutical 
companies employ for the monitoring of their medication. This includes the use of 
serial bar codes and RFID tagging.53 Pharmaceutical companies use these tactics 
with the hope that they are able to track and stop counterfeit medication from 
entering their supply chain.54 During the manufacturing process, a unique identity is 
added to each stock unit and remains with it through the supply chain.55 The theory 
is that a patient would be able to use their cell phone to text the unique serial number 
on the medication to a centralized entity that would then help to verify the legitimacy 
of the drug.56 The legitimacy of the drug would be verified based on the prior search 
history so if that serial number had been searched before, the customer would know 
that it is counterfeit.57 However, if the medication has not been searched before then 
in theory the drug is authentic.58 The issue with this method is that it assumes that 
those counterfeiters do not have access to the centralized server. The system also 
relies on the ability of elderly, dyslexic, and foreign individuals to put the correct 
number into the system. What if a counterfeit medication is identified as legit, but is 
indeed false because a hacker or internal personnel was able to input new serial 




53 Claire Swedberg, RFID Tracks Specialty Drugs Through Pharmaceutical Network, RFID J. 
(Aug. 29, 2018), https://www.rfidjournal.com/articles/pdf?17782. 
54 Id. 
55 Id. 
56 Alberto Coustasse et al., Could the Pharmaceutical Industry Benefit from Full-Scale Adoption of 
Radio-Frequency Identification (RFID) Technology with New Regulations?, 13 PERSP. HEALTH INFO. 
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numbers? The current use of serial codes also relies on problematic issues such as 
the visibility and sizing on varying package labeling. 
The current method of detection often relies on customs and pharmacy 
employees being able to distinguish a well-made counterfeit from the original. With 
the recent advancements in technology, counterfeiters now have the ability to use 
systems that convert the counterfeit item into a 3D representation of the original 
making it even more difficult for detection.59 To solve these issues, many 
pharmaceutical companies have added visible security features to their packaging.60 
These security features often include holograms, special ink, and embossing.61 To 
further enhance their security, many pharmaceutical companies have been 
experimenting with employing the use of ink that is invisible to the naked eye.62 
These methods allow for easy identification of counterfeits, but also requires that the 
pattern or code remain a secret from potential counterfeiters because once it is 
known, it will be reproduced rather quickly.63 
B. Revising Status Quo 
The Obama Administration implemented legislation that now requires 
pharmaceutical companies to include a serial number on prescription drug packaging 
to enable tracking of medication from the manufacturer to the pharmacy or doctor’s 
office.64 A potential solution is to create an app that allows for a consumer to enter 
the serial number from the packaging to verify that their medication came, for 
example, from Bayer’s manufacturing plant to the CVS drugstore, where they would 
like to purchase it. As a great step in the direction of transparency, this regulation is 
expected to tighten up and standardize the pharmaceutical supply chain by making it 
more difficult for counterfeit medications to enter it. If counterfeits actually are able 
to infiltrate the supply chain, it helps authorities identify the potential entry point. 
                                                          
59 Robert Service, You could soon be manufacturing your own drugs—thanks to 3D printing, SCI. 
(Jan. 18, 2018), http://www.sciencemag.org/news/2018/01/you-could-soon-be-manufacturing-your-own-
drugs-thanks-3d-printing. 
60 Dipika Bansal et al., Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective, SCI 




64 Erich D. Brechtelsbauer et al., Review of the 2015 Drug Supply Chain Security Act, HOSP PHARM 
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The method being proposed by the industry is a track and trace system that uses 
the ePedigree technology or 2D barcodes.65 The system uses randomized serial 
numbers on each package of medication.66 The authenticity of each medication is 
verified by entering the serial number located on the package into a repository system 
that was entered at the point of manufacturing.67 This can allow for verification at 
each point of the supply chain.68 The system is only effective if the supply chain of 
that medication is verified before being sold to patients. The issue with this system 
is that, as mentioned above, some pharmacies and doctors’ offices have been found 
to circumvent purchasing legitimate medications. 
Even before reaching the patient, medications travel through a vast network of 
retailers, distributors, transporters, storage facilities, and suppliers that participate in 
manufacturing, delivery, and sales, yet the journey of the medication remains an 
unseen dimension to the end consumer. There is a growing effort by the FDA’s 
Division of Supply Chain Integrity “to reduce threats to the global drug supply chain 
through increased transparency and accountability, effective enforcement, and 
promotion of proactive industry vigilance and voluntary compliance.”69 When 
pharmaceuticals retain the full chains of custody, it makes it rudimentary and 
difficult to verify.70 
Verification of the authenticity of the medication should be placed in the hands 
of consumers.71 No single organization should be trusted to monitor all of its 
medication data for the supply chain.72 Relying on a single entity allows for a single 
point of weakness that is vulnerable to bribery, social engineering, and other forms 
of hacking.73 Currently, access to the repository system would stop with the 
pharmacies, but Blockchain creates a unique opportunity for the healthcare industry 
to provide transparency for its consumers. Blockchain has the ability to serve as the 
                                                          
65 Renee Bassett, E-Pedigree: How Automation Secures the Pharmaceutical Supply Chain, 





69 Division of Supply Chain Integrity, U.S. Food & Drug Admin., https://www.fda.gov/Drugs/ 
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repository for all of the points in the pharmaceutical supply chain. If the supply chain 
data was gathered and verified by third parties, it allows for the data being monitored 
to be unbiased. 
VII. WHAT IS SUPPLY CHAIN ON BLOCKCHAIN? 
Pharmaceutical supply chain refers to the process of medication production, 
processing, transportation, distribution, to consumption and disposal of expired 
goods. Traceability in the pharmaceutical industry is critical for its revenue and 
corporate compliance.74 Traceability allows pharmaceutical companies to locate a 
lot of individual medication and follow its history in the supply chain from 
manufacturer to consumer.75 Traceability is a mandatory requirement for compliance 
with many government entities, increasing security and the confidence for patients.76 
With the emergence of new technologies like IoT and Blockchain technologies, 
technology has the potential to create transparency for a complex supply chain.77 
This can be accomplished by storing the cryptographic hashes of each individual 
device firmware onto the blockchain.78 The blockchain will create a permanent 
record of device configuration and state.79 Storage of the records on the blockchain 
“can be used to verify that a given device is genuine and that its software and settings 
have not been tampered with or breached.”80 Tools like IoT sensors have the capacity 
to provide real-time data on location and timestamps throughout the supply chain.81 
                                                          
74 THE KAISER FAMILY FOUND., supra note 5. 
75 Henry M. Kim & Marek Lasakowski, Towards an Ontology-Driven Blockchain Design for 
Supply Chain Provenance (Mar. 2018) (unpublished manuscript) (on file with Wiley Online Library). 
76 Id. 
77 Amit Chourey, 5 ways IoT can digitally transform pharma supply chain, LINKEDIN (Feb. 22, 
2017), https://www.linkedin.com/pulse/5-ways-iot-can-digitally-transform-pharma-supply-chain-amit-
chourey. 
78 Shermin Voshmgir & Valentin Kalinov, Crytography & Blockchain—Part 2, BLOCKCHAINHUB 
(Sept. 10, 2018), https://blockchainhub.net/blog/blog/cryptography-blockchain-bitcoin (Cryptographic 
hashing is a mathematical method for transforming large amounts of data into a unique string of text that 
are difficult to imitate. Any piece of data can be hashed, no matter its size or type. A hash is designed to 
act as a one-way function — you can put data into a hashing algorithm and get a unique string, but if you 
come upon a new hash, you cannot decipher the input data it represents.). 
79 Evans, supra note 16. 
80 Nir Kshetri, Can Blockchain Strengthen the Internet of Things?, 19 IT PROF’L 68 (Aug. 2017), 
http://libres.uncg.edu/ir/uncg/f/N_Kshetri_Can_2017.pdf. 
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This technology would increase data integrity, making it nearly impossible for 
counterfeiters to tamper with the records of the medication. 
The blockchain, serving as a shared database, offers highly secure and 
immutable access to the supply chain.82 A blockchain is a decentralized virtual ledger 
of transactions that are distributed amongst a network of computers (nodes).83 There 
is not a single computer that governs the data being added to the blockchain.84 For a 
transaction to be uploaded to the blockchain, there must be a consensus of nodes on 
that blockchain which would have to mathematically verify the transaction.85 Before 
information can be verified by the other nodes on the blockchain, the author of the 
data must be authenticated.86 Authors are authenticated by their digital signature, a 
cryptographic mechanism that is similar to a physical signature but is more secure.87 
Digital signatures also enable a party to prove their identity for each transaction 
without the worries of being impersonated.88 The requirement of a digital key 
prevents parties within the company from adding information to the blockchain 
unless the worker has access to the digital key.89 The blockchain is ideal for 
monitoring and tracking because unlike traditional systems, which often have 
heterogeneous types of data being inputted from various sources, it stores 
information based on each digital signature used for each interaction.90 The use of a 
digital key makes it possible to verify and audit the actions of others within the 
blockchain.91 
Blockchain offers pharmaceutical companies, health care providers, 
distributors, and pharmacies an inter-organizational recordkeeping platform, 
multiparty aggregation storage for a large number of sources, and provenance 
tracking.92 Each of the participants in a protected supply chain will be assigned 
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registration of a unique digital identity, linking their actual identity with their 
blockchain-based digital identity allowing for them to interact on the blockchain as 
they complete their role in the supply chain.93 
In order for data that is uploaded to the blockchain to be understood by all 
parties, there must be a common interpretation of the data. Because of the 
immutability of the blockchain, each party that is looking at the blockchain will be 
able to see the original data stored on the blockchain by the manufacturer, which 
cannot be altered.94 This means that blockchain reduces fraud and errors, reduces 
delays from paperwork, identifies issues faster, and increases consumer and partner 
trust. The trust that currently exists is based on the reputation of the pharmacy or 
pharmaceutical company. 
Using blockchain to maintain a pharmaceutical company’s supply chain can 
make it possible to contain an IoT security breach in a systematic manner when there 
is the discovery of a breach. The pharmaceutical company would be able to pinpoint 
when the counterfeited medications enters the supply chain. Blockchain can assist in 
the facilitation of handling and dealing with instances such as recalls due to security 
vulnerabilities. The transparency of blockchain makes it possible for the company to 
trace back every product to the origin of the raw materials, and transactions can be 
linked to the identity of the source. IoT-linked security crises, such as stolen 
medication, can be linked to the source instantly which allows for the company to 
then notify the authorities instantly. Indeed, notification of authorities could be 
programmed into the blockchain if each party uses a smart contract. Smart contracts 
are self-executing electronic contracts that are coded on the blockchain between 
members of the blockchain community. Smart contracts are an automated computer 
process that is coded to receive inputs from both parties and facilitates and to verify 
or enforce the negotiation or performance of that contract as defined by 
predetermined instructions. 
The pharmaceutical company could have the notification come to a member of 
the company to verify the breach before notifying the authorities. The use of the 
smart contract will allow for each duty defined in the contract to be verified by an 
IoT device, therefore triggering non-performance by either party. This allows for the 
pharmaceutical company to monitor the performance of each vendor associated with 
its supply chain. The instant notification of the breach allows the pharmaceutical 
company to confine the incident before it enters the market. The use of the 
blockchain by consumers will also allow the pharmaceutical company to contain 
counterfeit medications by giving consumers the ability to notify the company when 
it purchases counterfeit medications. Consumers would be able to detect counterfeit 
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medication by scanning each prescription’s QR code, which is then linked back to 
the blockchain of the pharmaceutical company. 
VIII. QR CODE PROVENANCE 
The QR code has become widely adopted in the food supply chain due to its 
faster readability, larger storage capacity, and cost.95 QR coding prescription 
medication can be a powerful authentication method for pharmaceutical 
companies.96 QR code is a 2D matrix code that contains information in a vertical and 
horizontal direction and has a low level of error corrections.97 QR coding makes it 
difficult for counterfeiters to copy or replace the code, whereas the current method 
of applying serial numbers to the packaging of medications can be easily 
duplicated.98 QR codes allow for the storage information or data for the identification 
and tracking for monitoring of drugs authenticity.99 A scanner such as a smartphone 
with a QR code scanner app can be used to access this information.100 
QR codes that are printed directly onto the medication are then linked to a 
private blockchain owned by the pharmaceutical company. This allows consumers 
to verify the authenticity of the drug; a patient can do a quick scan to get information 
on the pharmaceutical drug’s supply chain. By scanning the medication, the patient 
will not only see the supply chain, but it will also reveal medical information about 
the medication itself. This could help ensure that an individual is not taking the 
wrong medication or medication from outside of the pharmaceutical company’s 
supply chain. 
The use of QR codes also allows for the pharmaceutical company to detect the 
point of entrance for counterfeit drugs, allowing for the pharmaceutical companies 
to react in a timely manner to prevent it from reaching their consumers.101 If the 
pharmaceutical company does not respond fast enough, QR codes put power in the 
hands of consumers by allowing them to know in real time if the medication is 
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counterfeit. Pharmaceutical companies and/or government agencies can now start a 
reporting program for consumers who purchase counterfeit medications to notify 
others of the websites and social media pages that they purchased from. This 
information can be critical for providing the evidence that is needed to remove a 
social media posting or website or at least provide advisory notification. 
IX. CONTRACTING WITH THE PHARMACEUTICAL COMPANY 
Smart phones have evolved dramatically over the past few years and have 
increased in functionality and computing power.102 One of the most notable 
advancements has occurred in a smart phone’s imaging and video capability.103 
Smart phones, therefore, have the ability to be used for digital authentication on the 
fly for the detection of counterfeit medication.104 The ideal scenario that would best 
address counterfeit medication would utilize smart contracting with the consumer 
and pharmaceutical company.105 The consumer would go online and order their 
medication directly from the pharmaceutical company, thereby creating a smart 
contract with the company. Similar to when you order pizza from Dominos, the 
consumer would have access to each important step in the supply chain, up to 
delivery to their door.106 This creates confidence with the consumer that their 
medication is genuine. In situations where the consumer is ordering medication from 
a doctor’s office or pharmacy, the consumer would be added as an additional step to 
the supply chain. This allows the consumer to see where the drug has been before it 
was in their possession. The aim of smart contracting is to create transparency by 
documenting provenance. 
The use of QR codes and smart phone apps also allows the pharmaceutical 
company to get feedback from customers, regarding the effectiveness, content, and 
other subjective evaluations for the medication.107 This information is essential for 
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the pharmaceutical company’s quality control and compliance programs. As 
previously mentioned, it allows for warning information for potential problems. If a 
single QR code appears in more than one location, the pharmaceutical company can 
reach out to the consumers instantly to recall the medication due to potential 
counterfeit issues. The pharmaceutical company would be able to step in quickly to 
ensure that the patient does not continue on the counterfeit, allowing the patient to 
go untreated. 
Government agencies are still trying to determine the level of impact from the 
sale of Avastin that lacked an active ingredient which patients needed to survive.108 
The FDA found that nineteen clinics in California, Texas, and Illinois purchased the 
counterfeit version of the drug from Montana Health Care Solutions.109 The drugs 
appear genuine to physicians as they were labeled with the drug’s name and the 
manufacturer but did not contain Avastin, nor a generic, or the same active 
ingredient.110 There are only eight distributors that are authorized to sell Avastin to 
hospitals and doctor offices, but Montana Health Care Solutions was not listed as 
one.111 If the patients or physicians were able to see the supply chain of the drug, 
they would have realized that the drug did not lead back to the manufacturer, Roche. 
X. CAN THE QR-CODE/BLOCKCHAIN BE THE ANSWER TO THE OPIOID 
COUNTERFEIT CRISIS 
The number of Americans that are dying from opioids has increased 
dramatically in recent years, and legislatures are scrambling to find solutions to fix 
the situation. Fentanyl, a synthetic opioid, is often prescribed to patients to treat 
severe pain.112 Counterfeit fentanyl is being manufactured in countries like China 
and imported into America. U.S. law enforcement is finding an increased number of 
fentanyl-laced medications, as well as street drugs, that resemble the authentic 
version of the medication. The NABP found in its recent publication that 40% of 
online sites that sell controlled substances, which includes opioids that are frequently 
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linked to fentanyl-related to overdoses.113 In fact, the most popular controlled 
substance sold on these sites was Xanax, which counterfeit often contains fentanyl.114 
Counterfeit fentanyl has been linked to an increase in seizures and deaths, resulting 
in more than 49,068 American deaths in 2017 alone.115 Of these deaths, 66% were 
caused by opioids, including fentanyl.116 
The use of blockchain will give distributors the ability to do their due diligence 
on licensed pharmacies, hospitals, and other dispensaries who are looking to 
purchase controlled substances. The transparency of the blockchain allows for 
vetting the purchaser by internal and external experts before granting permission to 
ship. The transparency of the blockchain also allows for the employment of 
sophisticated technology, like Libra, that monitors the ordering of controlled 
substances.117 If any entity exceeds the allotted recommendations, the program alerts 
the other points up stream of the pharmacy or hospital for further analysis and 
possible cancellation. Information on the blockchain is timestamped, which allows 
for entities to assemble daily reports of all opioid medication orders for the FDA 
with ease. The blockchain reports would contain the hash used by each entity, which 
could be assigned in a private blockchain; the quantity of opioid medication for each 
hash; and the type of opioid medication purchased by each hash. If a pharmaceutical 
company decides to use a private blockchain for its supply chain, it could assign a 
unique hash for each licensed pharmacy, hospital, or other dispensary. Assigning a 
unique hash allows for the owner of the blockchain, the pharmaceutical company, to 
ensure that all of the downstream customers are licensed by regulatory agencies or 
patients with accurate prescriptions. These measures will help pharmaceutical 
companies and other points in the supply chain from sending thousands of suspicious 
orders to entities that are not licensed or that are licensed but are abusing their 
authority. 
XI. CONCLUSIONS 
Counterfeit medications are an issue that government entities and 
pharmaceutical companies must address to help protect their citizens and consumers. 
The driving force for the change in laws and the procedures implemented by 
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government entities and pharmaceutical companies will be the opioid crisis. With 
the deaths of patients who have purchased counterfeit opioids ranging in the tens of 
thousands, the new era of drug distribution compliance will alter the way the 
pharmaceutical supply chain functions for the better. Without placing the power in 
the consumer’s hands, the new procedures will not tackle the problem of counterfeit 
drugs completely because of access to unlicensed pharmacies and the internet. There 
is a need to make track and trace technology a global standard for the pharmaceutical 
supply chain to ensure the safety of the consumers. 
Real-time tracking and tracing of medication will help to ensure the safety and 
quality of medication in the pharmaceutical supply chain. The use of QR code, IoT 
technologies, and blockchain technology proposed in this paper will help to create a 
platform for integrated tracking and tracing for medication. QR codes can be 
imbedded on each pill, highlighting its journey and critical medication information 
from the pharmaceutical company. The technical architecture of an IoT-based 
blockchain tracking and tracing platform allows not only for item level tracking of 
each pill but also for the entire journey of the medication in the pharmaceutical 
supply chain to be known in real-time. The use of the blockchain platform enables 
information sharing among all of the involved parties along the pharmaceutical 
supply chain allowing full transparency for issues that arise during the journey to the 
consumer. Finally, the transparency provided by the blockchain could identify 
responsible parties when safety incidents happen, facilitating timely responses to 
protect consumer health, in situations such as the opioid crisis. 
Implementation of a blockchain system for pharmaceuticals will require all of 
the parties involved in the pharmaceutical supply chain. First, the scalability and 
compatibility of the QR code, IoT, and blockchain should be further evaluated in 
more real-life cases as it has been in the food supply chain. Second, the blockchain 
data analytics tools should be further explored to support the operational 
optimization during the pharmaceutical supply chain. Finally, an effective warning 
system should also be developed. Doing so will protect consumers and decrease the 
likelihood of tragedies like the opioid crisis. 
